AM
Therapeutic Areas
Rege Nephro Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Tamibarotene | Autosomal Dominant Polycystic Kidney Disease (ADPKD) | Preclinical |
| NPC Cell Therapy | Renal Diseases | Preclinical |
| EPO-producing Cell Therapy | Renal Anemia | Preclinical |
| Drug | Indication | Phase |
|---|---|---|
| Tamibarotene | Autosomal Dominant Polycystic Kidney Disease (ADPKD) | Preclinical |
| NPC Cell Therapy | Renal Diseases | Preclinical |
| EPO-producing Cell Therapy | Renal Anemia | Preclinical |